Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
about
Significant roles played by interleukin-10 in outcome of pregnancyCox-2 and IL-10 polymorphisms and association with squamous cell carcinoma of the head and neck in a Korean sampleAssociation of interleukin-10 gene polymorphisms with breast cancer in a Chinese population.Global transcriptional analysis for biomarker discovery and validation in cellular therapies.Quality assessment of cellular therapies: the emerging role of molecular assays.Immunologic response to tumor ablation with irreversible electroporation.Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cellsOccupational exposure to trichloroethylene and serum concentrations of IL-6, IL-10, and TNF-alpha.Potency analysis of cellular therapies: the emerging role of molecular assaysCharacterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients.Association of serum cytokines with colorectal polyp number and type in adult males.A Common SNP of IL-10 (-1082A/G) is Associated With Increased Risk of Premenopausal Breast Cancer in South Indian WomenSignificant roles played by IL-10 in Chlamydia infections.Genetic variations in multiple myeloma I: effect on risk of multiple myeloma.Is the IL-10 promoter polymorphism at position -592 associated with immune system-related diseases?The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis.Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.Association between pro-(IL-8) and anti-inflammatory (IL-10) cytokine variants and their serum levels and H. pylori-related gastric carcinogenesis in northern India.Clinical significance of IL-2 and IL-10 gene polymorphisms and serum levels in patients with basal-cell carcinoma.Functional genetic variability at promoters of pro-(IL-18) and anti-(IL-10) inflammatory affects their mRNA expression and survival in prostate carcinoma patients: Five year follow-up study.Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls.Association of interleukin-10 promoter polymorphism (-1082 g/a) and gastric cancer in andhra pradesh population of South India.The paradox of IL-10-mediated modulation in cervical cancer.Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.Bicarbonate transport inhibitor SITS modulates pH homeostasis triggering apoptosis of Dalton's lymphoma: implication of novel molecular mechanisms.Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study.Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population.IL-10 polymorphisms and prostate cancer risk: a meta-analysis.Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.Interleukin promoter polymorphisms and prognosis in colorectal cancerThe polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT
P2860
Q26747752-76A43F25-138C-44DE-8757-4D5CD209A8F3Q33935284-C212C1EE-57C6-4CFD-9749-6EC389EAC3A4Q34008603-03404735-292B-48C6-A099-DE944E94B7A9Q34171422-B7EFCD0A-537D-401F-8B68-1B16E62D7BA3Q34316777-094D2B99-4782-4F20-AE9F-1CA7660D17ABQ34472105-5B131DA6-DE52-4EC9-87A2-7BA19E3ABF72Q35067193-0019E0C0-AE1B-49A9-93B2-3926CB751BC7Q35180423-46ED0BBF-E7EA-4B36-9343-798A63BAA8CDQ35840586-334096DA-5796-441A-9369-B8E8C9F15D40Q36038030-45E5BC19-1473-4942-9D4B-4DFABA64AE04Q36074261-B81B6037-7622-4EB0-A3D3-58D542F4B48EQ36163313-891D1567-F096-4D6B-9521-81CAAA68398AQ37845177-7875BC4D-D4A5-416A-8BE7-39D2C6107858Q37924891-4C14B03A-ED2B-4F12-9A81-EC2F0E0CA016Q38034076-8934C21E-E14B-4CBF-9AA7-59478CCF5400Q38416094-0E072B47-A5A5-416D-B200-479DDA99FF7CQ38482170-E4A5F0E5-C90B-4848-B98A-6D5748A0A78DQ40994273-46254FAF-3069-4C62-9431-0F26B8FF7334Q41095136-0A424B90-BF23-495B-8E77-F727ADA33D22Q41478911-BC1D9315-BD7B-4C71-BA67-A585A1350C33Q41867161-5537C49B-C79E-4F21-838A-1ED7A950CA63Q42010815-078BAE48-3C60-4CDF-B1EF-16F78FC9E015Q42571106-6ABC8E7A-A40E-4429-AF7F-DAAC8CAC97B5Q42721869-DD09BE2D-3CAA-403D-9BFC-1A2C5911DA40Q46852154-AD9C4CF8-B051-41D2-AC50-A9867427596EQ47754476-839C911F-4EDB-4600-8591-97B39632083EQ47831802-628F8884-7FD4-45C3-B892-80DA1CC1B4A7Q53080924-A2BDA045-8D30-48FC-A474-E1F459359F20Q53319379-98D99054-85B0-45E9-BBD5-DF4546F7F5DAQ57610493-C2FD0A9C-59EE-44C6-AD46-7433D6177CD1Q59245216-54481230-8DC1-4E6E-AEAD-BF808110DDF7
P2860
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
@ast
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
@en
type
label
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
@ast
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
@en
prefLabel
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
@ast
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
@en
P1433
P1476
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
@en
P2093
Matthew J Rose-Zerilli
W Martin Howell
P2888
P304
P356
10.1007/S10689-005-0072-3
P577
2006-01-01T00:00:00Z